Ovarian cancer is often caught late, with only 35% of patients surviving for 10 years or more in England. One doctor is ...

More women chose to have their tubes tied after Roe v. Wade was overturned in 2022, a new study shows, and the biggest ...

But I firmly believe we can also help the many thousands more who don’t have this genetic risk – by carrying out surgery to remove the fallopian tubes in women already earmarked for other ...

Human papillomavirus (HPV) and hyperactivated YAP1 form a YAP1-HPV oncogenic alliance to drive the malignant transformation ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

In addition to 510(k) clearance, FemChec, a contrast generating product, is an integral part of the confirmation test ...

Pamiparib (Baihuize) is an anti-neoplastic agent. It is formulated as capsules for oral route of administration. Baihuize is indicated for the treatment of patients with germline BRCA ...

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Fallopian Tube Cancer.

Rucaparib (Rubraca) is available on the NHS. It is a possible maintenance treatment for relapsed platinum-sensitive high-grade epithelial, ovarian, fallopian tube or primary peritoneal cancer that has ...

which are surgeries to close the fallopian tubes so the patient can no longer get pregnant. The data came from 36 states and Washington, D.C., and researchers categorized these places as “banned ...